1、 SU B,SHENG H,ZANG M,et al. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment:a meta-analysis of randomized controlled trials [J]. Endocrine,2015,48(1):107-115. SU B,SHENG H,ZANG M,et al. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment:a meta-analysis of randomized controlled trials [J]. Endocrine,2015,48(1):107-115.
2、 MABILLEAU G, MIECZKOWSKA A, CHAPPARD D. Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials [J]. Diabetes,2014,6(3):260-266. MABILLEAU G, MIECZKOWSKA A, CHAPPARD D. Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials [J]. Diabetes,2014,6(3):260-266.
3、 洪文婕,黄春仁,黄斌.二甲双胍和胰高糖素样多肽-1对2型糖尿病患者并发骨折恢复的影响[J]. 广州医药,2017,48(6):33-35,47. 洪文婕,黄春仁,黄斌.二甲双胍和胰高糖素样多肽-1对2型糖尿病患者并发骨折恢复的影响[J]. 广州医药,2017,48(6):33-35,47.
4、 KANAZAWA L,YAMAGUCHI T,YAMAMOTO M,et al. Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus[J]. Bone Miner Metab,2010,28(5):554-560. KANAZAWA L,YAMAGUCHI T,YAMAMOTO M,et al. Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus[J]. Bone Miner Metab,2010,28(5):554-560.
5、 HU X K, YIN X H, ZHANG H Q,et al. Liraglutide attenuates the osteoblastic differentiation of MC3T3 E1 cells by modulating AMPK/mTOR signaling[J]. Mol Med Rep, 2016,14(4):3662-3668. HU X K, YIN X H, ZHANG H Q,et al. Liraglutide attenuates the osteoblastic differentiation of MC3T3 E1 cells by modulating AMPK/mTOR signaling[J]. Mol Med Rep, 2016,14(4):3662-3668.
6、 赵辰荷,梁璟,杨吟秋,等. 胰高血糖素样肽-1对骨代谢的影响和潜在机制[J]. 复旦学报(医学版),2017,44(3):369-373. 赵辰荷,梁璟,杨吟秋,等. 胰高血糖素样肽-1对骨代谢的影响和潜在机制[J]. 复旦学报(医学版),2017,44(3):369-373.
7、 ZHEN D, CHEN Y, TANG X. Metformin reverses the deleterious effects of high glucose on osteoblast function[J]. J Diabetes Complications,2010,24(5):334-344. ZHEN D, CHEN Y, TANG X. Metformin reverses the deleterious effects of high glucose on osteoblast function[J]. J Diabetes Complications,2010,24(5):334-344.
8、 GILBERT M P, PRATLEY R E. The impact of diabetes and diabetes medications on bone health[J]. Endocr Rev, 2015, 36(2):194-213. GILBERT M P, PRATLEY R E. The impact of diabetes and diabetes medications on bone health[J]. Endocr Rev, 2015, 36(2):194-213.
9、 KARIM L, BOUXSEIN M L. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties[J]. Bone,2016,82(1):21-27. KARIM L, BOUXSEIN M L. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties[J]. Bone,2016,82(1):21-27.
10、 HAMANN C, KIRSCHNER S, GüNTHER K P, et al. Bone, sweet bone osteoporotic fractures in diabetes mellitus[J]. Nat Rev Endocrinol,2012,8(5):297-305. HAMANN C, KIRSCHNER S, GüNTHER K P, et al. Bone, sweet bone osteoporotic fractures in diabetes mellitus[J]. Nat Rev Endocrinol,2012,8(5):297-305.
11、 FORSLUND J M, ARCHDEACON M T. The pathobiology of diabetes mellitus in bone metabolism, fracture healing, and complications[J]. Am J Orthop,2015,44(10):453-457. FORSLUND J M, ARCHDEACON M T. The pathobiology of diabetes mellitus in bone metabolism, fracture healing, and complications[J]. Am J Orthop,2015,44(10):453-457.
12、 王覃,陈德才. 糖尿病对骨质疏松症的影响及其机制[J]. 中华糖尿病杂志, 2016,8(1):5-7. 王覃,陈德才. 糖尿病对骨质疏松症的影响及其机制[J]. 中华糖尿病杂志, 2016,8(1):5-7.
13、 丁卓玲,熊杏安,肖硕.利拉鲁肽在2型糖尿病治疗中的应用进展[J]. 实用药物与临床,2014,17(5):615-619. 丁卓玲,熊杏安,肖硕.利拉鲁肽在2型糖尿病治疗中的应用进展[J]. 实用药物与临床,2014,17(5):615-619.
14、 OGATA M, IDE R, TAKIZAWA M, et al. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes[J]. Nutrition, 2015,31(11-12):1394-1401. OGATA M, IDE R, TAKIZAWA M, et al. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes[J]. Nutrition, 2015,31(11-12):1394-1401.
15、 CARNEVALE V, ROMAGNOLI E, D'ERASMO L,et al. Bone damage in type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis, 2014,24(11):1151-1157. CARNEVALE V, ROMAGNOLI E, D'ERASMO L,et al. Bone damage in type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis, 2014,24(11):1151-1157.
